AI-powered model predicts EGFR mutations from H&E-stained slides, demonstrating robust performance across diverse clinical ...

The firm's next-generation pancreatic cancer test looks for five biomarkers that are indicative of early-stage disease.

We recently published a list of the 12 Best Diagnostics Stocks to Invest In Right Now. In this article, we are going to take ...

American Institute of Pathology & Laboratory Sciences (Ampath) has expanded its operations in Punjab with the launch of a new ...

We recently published a list of the 12 Best Diagnostics Stocks to Invest In Right Now. In this article, we are going to take ...

We recently published a list of the 12 Best Diagnostics Stocks to Invest In Right Now. In this article, we are going to take ...

We recently published a list of the 12 Best Diagnostics Stocks to Invest In Right Now. In this article, we are going to take a look at where Natera, Inc.

Founded in 2013, Techcyte is transforming the practice of pathology with a unified pathology platform that digitizes lab workflows and offers AI tools that aim to improve the efficiency and accuracy ...

According to a report by Mordor Intelligence, the clinical diagnostics market has a size of $88.79 billion as of 2025.

Aiforia, a trusted provider of deep learning AI solutions for digital pathology, and Techcyte, a leader in AI-powered digital pathology systems, announced a strategic partnership to accelerate the ...